Taisho Set for Delisting as Early as April after Tender Offer Completed

Taisho Pharmaceutical Holdings said on January 16 that a tender offer related its management buyout (MBO) plan has been successfully completed, opening the way for its delisting as early as April. The tender offer had been made by Otemon, a...read more